Identifying biomarkers for Alzheimer's disease and related dementias
Core F: Biomarker Core
This study is working to find new ways to detect and monitor Alzheimer's disease and related dementias earlier and more accurately, so that patients can get better care, and it’s being led by a team of experts at Boston University.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University Medical Campus NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10873351 on NIH RePORTER |
What this research studies
This research focuses on the development and validation of biomarkers that can aid in the early detection, diagnosis, and monitoring of Alzheimer's disease and related dementias. Led by experienced clinician-scientists, the Biomarker Core at Boston University will analyze fluid biospecimens and neuroimaging data to improve understanding of these conditions. The initiative aims to centralize biomarker efforts and collaborate with other research cores to enhance diagnostic accuracy and patient care. By banking and distributing these biospecimens, the research will support both local and national studies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals experiencing symptoms of Alzheimer's disease or related dementias, as well as those at risk for these conditions.
Not a fit: Patients with non-Alzheimer's related cognitive impairments or those without any cognitive symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and earlier diagnoses of Alzheimer's disease and related dementias, improving patient outcomes.
How similar studies have performed: Previous research has shown success in using biomarkers for diagnosing Alzheimer's disease, indicating that this approach is promising and builds on established findings.
Where this research is happening
Boston, United States
- Boston University Medical Campus — Boston, United States (Active)
Researchers
- Principal investigator: Goldstein, Lee E. — Boston University Medical Campus
- Study coordinator: Goldstein, Lee E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.